Daniel Tardiff - 01 Oct 2025 Form 3 Insider Report for Camp4 Therapeutics Corp (CAMP)

Role
Chief Scientific Officer
Signature
/s/ Daniel Tardiff, PhD
Issuer symbol
CAMP
Transactions as of
01 Oct 2025
Net transactions value
$0
Form type
3
Filing time
10 Oct 2025, 16:11:21 UTC
Next filing
22 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tardiff Daniel Chief Scientific Officer ONE KENDALL SQUARE, BLDG 1400 WEST, 3RD FLOOR, CAMBRIDGE /s/ Daniel Tardiff, PhD 10 Oct 2025 0002089301

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CAMP Stock Option (Right to Buy) 01 Oct 2025 Common Stock 22,289 $9.08 Direct F1
holding CAMP Stock Option (Right to Buy) 01 Oct 2025 Common Stock 22,289 $9.08 Direct F2
holding CAMP Stock Option (Right to Buy) 01 Oct 2025 Common Stock 25,000 $3.86 Direct F3
holding CAMP Stock Option (Right to Buy) 01 Oct 2025 Common Stock 5,000 $3.53 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option has a vesting start date of September 18, 2023. The shares underlying the option vested with respect to 25% of the shares on the first anniversary of the vesting start date and vest as to the remainder in equal monthly installments on the 36 subsequent monthly anniversaries of the vesting start date.
F2 The shares underlying the option vested with respect to 25% of the shares on September 18, 2024 and vest as to the remainder in equal monthly installments on the 39 subsequent monthly anniversaries of December 18, 2023.
F3 The shares underlying the option vest in equal monthly installments over a period of four years commencing from April 1, 2025.

Remarks:

Exhibit 24 - Power of Attorney